Phase I, double-blind, placebo-controlled, ascending, single-dose, safety, tolerability and pharmacokinetic study of SRX251 capsules in healthy female volunteers
Phase of Trial: Phase I
Latest Information Update: 10 Aug 2007
At a glance
- Drugs SRX 251 (Primary)
- Indications Aggression; Dysmenorrhoea
- Focus Adverse reactions
- 10 Aug 2007 Status changed from recruiting to completed.
- 28 Jun 2007 New trial record.